Sexually Transmitted Infection and Pelvic Inflammatory Disease

doi:10.1017/9781108582322.026

Chapter 24 - Sexually Transmitted Infection and Pelvic Inflammatory Disease

from Section 4 - Contraception and STIs

Published online by Cambridge University Press: 24 November 2021

Durba Raha

Edited by

Tahir Mahmood ,

Charles Savona-Ventura ,

Ioannis Messinis and

Sambit Mukhopadhyay

Show author details

Tahir Mahmood: Affiliation:
Victoria Hospital, Kirkcaldy
Charles Savona-Ventura: Affiliation:
University of Malta, Malta
Ioannis Messinis: Affiliation:
University of Thessaly, Greece
Sambit Mukhopadhyay: Affiliation:
Norfolk & Norwich University Hospital, UK

Book contents

Get access

Summary

This chapter discusses the STIs chlamydia, gonorrhoea, Trichomonas vaginalis (TV), genital warts, herpes, Mycoplasma genitalium (MG) and pelvic inflammatory disease (PID). HIV and syphilis are not covered. Chlamydia, gonorrhoea, TV, herpes and MG are diagnosed by PCR or NAAT testing. Warts and PID are predominantly diagnosed clinically. Management of all STIs involves discussion of information, both verbal and written, and advice on prevention by use of condoms and contact testing. Chlamydia, gonorrhoea, TV, MG and PID are managed by use of antibiotic regimens, which are described. Test of cure (TOC) is recommended for certain STIs (i.e. Gonorrhoea and MG) due to risk of antibiotic resistance. Treatment options during pregnancy and breastfeeding are discussed. Complications of the STIs where relevant are discussed.

Keywords

sexually transmitted infection pelvic inflammatory disease STI PID Trichomonas vaginalis Chlamydia gonorrhoea mycoplasma

Information

Type: Chapter
Information: The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
Gynaecology
, pp. 186 - 202

DOI: https://doi.org/10.1017/9781108582322.026 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Lanjouw, E, Ouburg, S, de Vries, HJ, et al. European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS 2016;27:333–348Google Scholar

European Centre for Disease Prevention and Control. Chlamydia infection. In: ECDC: Annual Epidemiological Report for 2016. Stockholm: ECDC, 2018.Google Scholar

Nwokolo, NC, Dragovic, B, Patel, S, et al. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS 2016;27:251–267.Google Scholar

Fifer, H, Saunders, J, Soni, S, et al. BASHH national guideline for the management of infection with Neisseria gonorrhoeae. 2019. Available at: www.bashhguidelines.org/media/1208/gc-2019.pdf.Google Scholar

European Centre for Disease Prevention and Control. Gonorrhoea infection. In: ECDC. Annual Epidemiological Report for 2016. Stockholm: ECDC, 2018.Google Scholar

Soni, S, Horner, P, Rayment, M, et al. BASHH guideline for management of Mycoplasma genitalium. 2018. Available at: www.bashhguidelines.org/media/1198/mg-2018.pdf.Google Scholar

Sherrard, J, Ison, C, Moody, J, et al. United Kingdom national guideline on the management of Trichomonas vaginalis. Int J STD AIDS 2014;25:541.Google Scholar

Gilson, R, Nathan, M, Sonnex, C, et al. UK national guidelines on the management of anogenital warts. 2015. Available at: www.bashhguidelines.org/media/1075/uk-national-guideline-on-warts-2015-final.pdf.Google Scholar

Patel, R, Kennedy, OJ, Clarke, E, et al. European guidelines for the management of herpes. Int J STD AIDS 2017;28:1366–1379.Google Scholar

Foley, E, Clarke, E, Beckett, VA, et al. Management of genital herpes in pregnancy RCOG and BASHH. 2014. Available at: www.rcog.org.uk/en/guidelines-research-services/guidelines/genital-herpes.Google Scholar

Ross, J, Guaschino, S, Cusini, M, Jensen, J. European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2017;29:108–114.Google Scholar

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the HTML of this chapter is currently unknown and may be updated in the future.